| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Am I or am I not proarrhythmic? Comparison of various classifications of drug TdP propensity
|
Wiśniowska, Barbara
|
|
2017
|
22 |
1 |
p. 10-16
7 p.
|
artikel
|
| 2 |
Chasing the personalized medicine dream through biomarker validation in colorectal cancer
|
Patil, Harshali
|
|
2017
|
22 |
1 |
p. 111-119
9 p.
|
artikel
|
| 3 |
Commercialisation of CAR T-cell therapies: business model spectrum
|
Malik, Nafees N.
|
|
2017
|
22 |
1 |
p. 1-4
4 p.
|
artikel
|
| 4 |
Contents page 1
|
|
|
2017
|
22 |
1 |
p. i-
1 p.
|
artikel
|
| 5 |
Contents page 2
|
|
|
2017
|
22 |
1 |
p. ii-
1 p.
|
artikel
|
| 6 |
Cyclooxygenase-2 in glioblastoma multiforme
|
Qiu, Jiange
|
|
2017
|
22 |
1 |
p. 148-156
9 p.
|
artikel
|
| 7 |
Defining drug response for stratified medicine
|
Lonergan, Mike
|
|
2017
|
22 |
1 |
p. 173-179
7 p.
|
artikel
|
| 8 |
Electrophysiological approaches to unravel the neurobiological basis of appetite and satiety: use of the multielectrode array as a screening strategy
|
Shaban, Hamdy
|
|
2017
|
22 |
1 |
p. 31-42
12 p.
|
artikel
|
| 9 |
Exploiting receptor tyrosine kinase co-activation for cancer therapy
|
Tan, Aik-Choon
|
|
2017
|
22 |
1 |
p. 72-84
13 p.
|
artikel
|
| 10 |
Fragment library design, synthesis and expansion: nurturing a synthesis and training platform
|
Ray, Peter C.
|
|
2017
|
22 |
1 |
p. 43-56
14 p.
|
artikel
|
| 11 |
In vivo fate of lipid-based nanoparticles
|
Qi, Jianping
|
|
2017
|
22 |
1 |
p. 166-172
7 p.
|
artikel
|
| 12 |
Macrophage polarization in response to epigenetic modifiers during infection and inflammation
|
Patel, Urmi
|
|
2017
|
22 |
1 |
p. 186-193
8 p.
|
artikel
|
| 13 |
Molecular imaging in oncology drug development
|
Mudd, Sarah R.
|
|
2017
|
22 |
1 |
p. 140-147
8 p.
|
artikel
|
| 14 |
Pharmaceutical and biomaterial engineering via electrohydrodynamic atomization technologies
|
Mehta, Prina
|
|
2017
|
22 |
1 |
p. 157-165
9 p.
|
artikel
|
| 15 |
Predicting toxicities in humans by nonclinical safety testing: an update with particular reference to anticancer compounds
|
Ahuja, Varun
|
|
2017
|
22 |
1 |
p. 127-132
6 p.
|
artikel
|
| 16 |
Recent advances in therapeutic recruitment of mammalian RNAi and bacterial CRISPR-Cas DNA interference pathways as emerging antiviral strategies
|
Chin, Wei-Xin
|
|
2017
|
22 |
1 |
p. 17-30
14 p.
|
artikel
|
| 17 |
Recombinant high-density lipoproteins and their use in cardiovascular diseases
|
Cao, Yi-ni
|
|
2017
|
22 |
1 |
p. 180-185
6 p.
|
artikel
|
| 18 |
Statin-associated myopathy and the quest for biomarkers: can we effectively predict statin-associated muscle symptoms?
|
Muntean, Danina M.
|
|
2017
|
22 |
1 |
p. 85-96
12 p.
|
artikel
|
| 19 |
Strategy for large-scale isolation of enantiomers in drug discovery
|
Leek, Hanna
|
|
2017
|
22 |
1 |
p. 133-139
7 p.
|
artikel
|
| 20 |
Structural features of subtype-selective EP receptor modulators
|
Markovič, Tijana
|
|
2017
|
22 |
1 |
p. 57-71
15 p.
|
artikel
|
| 21 |
Targeting the endocannabinoid system: future therapeutic strategies
|
Aizpurua-Olaizola, Oier
|
|
2017
|
22 |
1 |
p. 105-110
6 p.
|
artikel
|
| 22 |
The challenges of modulating the ‘rest and digest’ system: acetylcholine receptors as drug targets
|
VanPatten, Sonya
|
|
2017
|
22 |
1 |
p. 97-104
8 p.
|
artikel
|
| 23 |
The many roles of molecular complexity in drug discovery
|
Méndez-Lucio, Oscar
|
|
2017
|
22 |
1 |
p. 120-126
7 p.
|
artikel
|
| 24 |
The publishing and patenting strategies of successful university spinoffs in the biopharmaceutical industry
|
Erden, Zeynep
|
|
2017
|
22 |
1 |
p. 5-9
5 p.
|
artikel
|
Tijdschrift beschrijving